240 related articles for article (PubMed ID: 24980047)
1. TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
Xiao Y; Jin J; Chang M; Nakaya M; Hu H; Zou Q; Zhou X; Brittain GC; Cheng X; Sun SC
J Exp Med; 2014 Jul; 211(8):1689-702. PubMed ID: 24980047
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
3. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
4. Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.
Sriskantharajah S; Gückel E; Tsakiri N; Kierdorf K; Brender C; Ben-Addi A; Veldhoen M; Tsichlis PN; Stockinger B; O'Garra A; Prinz M; Kollias G; Ley SC
J Immunol; 2014 Apr; 192(8):3518-3529. PubMed ID: 24639351
[TBL] [Abstract][Full Text] [Related]
5. TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.
Wang Y; Wang S; Kelly CP; Feng H; Greenberg A; Sun X
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844241
[TBL] [Abstract][Full Text] [Related]
6. USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.
Liu X; Li H; Zhong B; Blonska M; Gorjestani S; Yan M; Tian Q; Zhang DE; Lin X; Dong C
J Exp Med; 2013 Jul; 210(8):1575-90. PubMed ID: 23825189
[TBL] [Abstract][Full Text] [Related]
7. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.
Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P
Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.
Hatziapostolou M; Koukos G; Polytarchou C; Kottakis F; Serebrennikova O; Kuliopulos A; Tsichlis PN
Sci Signal; 2011 Aug; 4(187):ra55. PubMed ID: 21868363
[TBL] [Abstract][Full Text] [Related]
9. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
10. Protein Kinase Serine/Threonine Kinase 24 Positively Regulates Interleukin 17-Induced Inflammation by Promoting IKK Complex Activation.
Jiang Y; Tian M; Lin W; Wang X; Wang X
Front Immunol; 2018; 9():921. PubMed ID: 29760709
[TBL] [Abstract][Full Text] [Related]
11. Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.
Kyrmizi I; Ioannou M; Hatziapostolou M; Tsichlis PN; Boumpas DT; Tassiulas I
J Leukoc Biol; 2013 Oct; 94(4):751-7. PubMed ID: 23898046
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
13. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
Yu P; Bamford RN; Waldmann TA
Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
[TBL] [Abstract][Full Text] [Related]
14. IkappaB kinase is an essential component of the Tpl2 signaling pathway.
Waterfield M; Jin W; Reiley W; Zhang M; Sun SC
Mol Cell Biol; 2004 Jul; 24(13):6040-8. PubMed ID: 15199157
[TBL] [Abstract][Full Text] [Related]
15. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.
Cui G; Qin X; Wu L; Zhang Y; Sheng X; Yu Q; Sheng H; Xi B; Zhang JZ; Zang YQ
J Clin Invest; 2011 Feb; 121(2):658-70. PubMed ID: 21266776
[TBL] [Abstract][Full Text] [Related]
19. Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
Tsatsanis C; Vaporidi K; Zacharioudaki V; Androulidaki A; Sykulev Y; Margioris AN; Tsichlis PN
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2987-92. PubMed ID: 18287049
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
